RECOVER队列中气管切开与功能、神经心理及医疗利用结局的关联
该研究为Towards RECOVER前瞻性观察研究的二次分析,纳入加拿大9个大学附属ICU中机械通气≥7天的内外科患者,比较气管切开(193/398,48.5%)与非气管切开患者的结局。气管切开患者年龄更大、机械通气时间和ICU/住院时间更长,ICU再入风险(OR 1.9)和住院死亡率(OR 2.6)更高,但1年死亡率无显著差异(HR 1.41,95%CI 0.88-1.2)。1年内气管切开患者FIM总分低7.7分,3个月起6MWT低12%、MRC评分低3.4分,多数肺功能指标低5-8%。气管切开患者出院时和1年时在家可能性更低。
要点
- 需机械通气≥7天的ICU幸存者中,48.5%(193/398)接受气管切开,中位时间为ICU第14天(IQR 8-0天,原文如此)。
- 气管切开患者住院死亡率更高(OR 2.6;95%CI 1.1-6.1),ICU再入风险更高(OR 1.9;95%CI 1.0-3.2),1年死亡率无显著差异(HR 1.41;95%CI 0.88-1.2)。
- 1年内气管切开患者FIM总分低7.7分(95%CI 2.2-13.2),3个月起6MWT低12%(p=0.0008)、MRC评分低3.4分(p=0.006)。
- 气管切开组多数肺功能指标低5-8%;SF36、IES、BDI-II两组相似。
- 气管切开患者专科就诊率(率比0.63;95%CI 0.28-2.4)和再住院(OR 0.82;95%CI 0.54-1.3)相似,但出院时和1年时在家可能性更低。
适用人群与场景
- 加拿大9个大学附属ICU中机械通气≥7天的内科/外科患者,纳入Towards RECOVER研究。
- 二次分析纳入398例ICU幸存者,其中193例(48.5%)接受气管切开。
研究设计与关键结果
- 研究设计:前瞻性观察研究的二次分析,比较气管切开与非气管切开患者;气管切开中位时间为ICU第14天(IQR 8-0天,原文如此)。
- 气管切开患者年龄更大、病情严重程度相似、机械通气时间及ICU和住院时间更长。
- 住院死亡率:气管切开组OR 2.6(95%CI 1.1-6.1);ICU再入OR 1.9(95%CI 1.0-3.2);1年死亡率HR 1.41(95%CI 0.88-1.2),无显著差异。
- 1年内FIM总分:气管切开组低7.7分(95%CI 2.2-13.2);SF36、IES、BDI-II两组相似。
- 3个月起6MWT:气管切开组低12%(p=0.0008);MRC评分低3.4分(p=0.006)。
- 肺功能:气管切开组多数指标低5-8%。
- 医疗利用:专科就诊率比0.63(95%CI 0.28-2.4),再住院OR 0.82(95%CI 0.54-1.3),均无显著差异;出院时和1年时在家可能性更低。
证据类型、等级与局限
- 证据类型:前瞻性观察研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于机械通气≥7天的ICU患者,气管切开与更高的住院死亡率(OR 2.6)和ICU再入风险(OR 1.9)相关,但1年死亡率无显著差异。
- 气管切开患者1年内功能独立(FIM总分低7.7分)和运动能力(6MWT低12%、MRC低3.4分)更差,出院时和1年时在家可能性更低,提示需关注其出院安置和康复负担。
- 气管切开组专科就诊和再住院率与非气管切开组相似。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Tracheostomy is commonly performed in critically ill patients requiring prolonged mechanical ventilation (MV). We evaluated the outcomes of tracheostomy in patients who received greater than or equal to 1 week MV and were followed for 1 year.
DESIGN: In this secondary analysis of a prospective observational study, we compared outcomes in tracheostomy versus nontracheostomy patients. Outcomes post ICU included Functional Independence Measure (FIM) subscales, 6-Minute Walk Test (6MWT), Short Form 36 (SF36), Medical Research Council (MRC) Scale, pulmonary function tests (PFTs), Impact of Event Scale (IES), Beck Depression Inventory-II (BDI-II), and vital status and disposition.
SETTING: Nine University affiliated ICUs in Canada.
PATIENTS: Medical/surgical patients requiring MV for 7 or more days who were enrolled in the Towards RECOVER Study.
MEASUREMENTS AND MAIN RESULTS: Of 398 ICU survivors, 193 (48.5%) received tracheostomy, on median ICU day 14 (interquartile range [IQR], 8-0 d). Patients with tracheostomy were older, had similar severity of illness, had longer MV duration and ICU and hospital stays, and had higher risk of ICU readmission (odds ratio [OR], 1.9; 95% CI, 1.0-3.2) and hospital mortality (OR, 2.6; 95% CI, 1.1-6.1), but not 1-year mortality (hazard ratio, 1.41; 95% CI, 0.88-1.2). Over 1 year, tracheostomy patients had lower FIM-Total (7.7 points; 95% CI, 2.2-13.2); SF36, IES, and BDI-II were similar. From 3 months, tracheostomy patients had 12% lower 6MWT (p = 0.0008) and lower MRC score (3.4 points; p = 0.006). Most PFTs were 5-8% lower in the tracheostomy group. Tracheostomy patients had similar specialist visits (rate ratio, 0.63; 95% CI, 0.28-2.4) and hospital readmissions (OR, 0.82; 95% CI, 0.54-1.3) but were less likely to be at home at hospital discharge and 1 year.
CONCLUSIONS: Patients who received tracheostomy had more ICU and hospital care and higher hospital mortality compared with patients who did not receive a tracheostomy. In 1 year follow-up, tracheostomy patients required a higher daily burden of care, expressed by FIM.
参考来源
- Mehta S, Brondani A, Tomlinson G, et al. Association Between Tracheostomy and Functional, Neuropsychological, and Healthcare Utilization Outcomes in the RECOVER Cohort. Crit Care Explor. 2022. PMID: 36248317. doi:10.1097/CCE.0000000000000768
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。